But Pauline, it may be rare when you consider every woman who has had chemotherapy, but when you take just those that have received docetaxal, it is not.
https://www.schmidtandclark.com/wp-content/uploads/Alopecia-FECdoce-Kluger-AnnOnco2012.pdfhttp://journals.lww.com/amjdermatopathology/Abstract/2011/06000/Permanent_Alopecia_After_Systemic_Chemotherapy__A.3.aspxand therefore any patient being offered docetaxal should be warned of this risk beforehand. I for one, would not have taken it if I'd known in advance.
It looks like the lawyers in the US are getting very excited at the prospect of the class actions they are going to
milk undertake. In Europe, apparently, the label for the drug has warned of the possibility of permanent hair loss for a decade, but in Australia, even the Policy Officers of the most important breast cancer advocacy group are denying it.